Related Experiment Videos
Olanzapine-induced respiratory failure
1Department of Medicine E, Chaim Sheba Medical Center, Tel-Aviv University, Sackler School of Medicine, Tel-Hashomer, Israel. mouallem@post.tau.ac.il
Summary
Olanzapine can cause somnolence, a side effect that may lead to serious respiratory issues in elderly patients with lung disease. Careful monitoring is recommended for this vulnerable population when initiating olanzapine treatment.
Area of Science:
- Geriatric Medicine
- Pharmacology
- Pulmonology
Background:
- Olanzapine is an atypical antipsychotic commonly used for treating psychiatric conditions.
- While generally considered safe, olanzapine can cause significant somnolence, affecting up to 39% of patients at a 15 mg daily dose.
Observation:
- A case study involving an elderly patient with pre-existing chronic lung disease is presented.
- This patient experienced carbon dioxide (CO2) narcosis and subsequent respiratory failure after commencing olanzapine therapy.
Findings:
- The severe sedative effects of olanzapine were identified as the likely cause of the life-threatening respiratory complication.
- This highlights a potential risk associated with olanzapine in patients with compromised respiratory function.
Implications:
- Elderly patients with chronic lung disease require vigilant observation when treated with olanzapine, particularly during the initial treatment phase.
- This case underscores the importance of considering respiratory status when prescribing olanzapine to at-risk populations.